Role of PI3K/AKT/mTOR signaling pathway and sirtuin genes in chronic obstructive pulmonary disease development-Reference-Cited by-同舟云学术

Role of PI3K/AKT/mTOR signaling pathway and sirtuin genes in chronic obstructive pulmonary disease development

Published:2023-09-08 Issue:5 Volume:27 Page:512-521
ISSN:2500-3259
Container-title:Vavilov Journal of Genetics and Breeding
language:
Short-container-title:Vestn. VOGiS

Author:

Korytina G. F.¹^ORCID,Akhmadishina L. Z.²^ORCID,Markelov V. A.¹^ORCID,Aznabaeva Y. G.³^ORCID,Kochetova O. V.²^ORCID,Nasibullin T. R.²^ORCID,Larkina A. P.²^ORCID,Khusnutdinova N. N.²^ORCID,Zagidullin N. Sh.³^ORCID,Victorova T. V.³^ORCID

Affiliation:

1. Institute of Biochemistry and Genetics – Subdivision of the Ufa Federal Research Centre of the Russian Academy of Sciences; Bashkir State Medical University

2. Institute of Biochemistry and Genetics – Subdivision of the Ufa Federal Research Centre of the Russian Academy of Sciences

3. Bashkir State Medical University

Abstract

Chronic obstructive pulmonary disease (COPD) is a multifactorial disease of the respiratory system which develops as a result of a complex interaction of genetic and environmental factors closely related to lifestyle. We aimed to assess the combined effect of the PI3K/AKT/mTOR signaling pathway (PIK3R1, AKT1, MTOR, PTEN) and sirtuin (SIRT1, SIRT3, SIRT6) genes to COPD risk. SNPs of SIRT1 (rs3758391, rs3818292), SIRT3 (rs3782116, rs536715), SIRT6 (rs107251), AKT1 (rs2494732), PIK3R1 (rs10515070, rs831125, rs3730089), MTOR (rs2295080, rs2536), PTEN (rs701848, rs2735343) genes were genotyped by real-time polymerase chain reaction (PCR) among 1245 case and control samples. Logistic regression was used to detect the association of SNPs in different models. Linear regression analyses were performed to estimate the relationship between SNPs and lung function parameters and smoking pack-years. Significant associations with COPD were identified for SIRT1 (rs3818292) (P = 0.001, OR = 1.51 for AG), SIRT3 (rs3782116) (P = 0.0055, OR = 0.69) and SIRT3 (rs536715) (P = 0.00001, OR = 0.50) under the dominant model, SIRT6 (rs107251) (P = 0.00001, OR = 0.55 for СT), PIK3R1: (rs10515070 (P = 0.0023, OR = 1.47 for AT), rs831125 (P = 0.00001, OR = 2.28 for AG), rs3730089 (P = 0.0007, OR = 1.73 for GG)), PTEN: (rs701848 (P = 0.0015, OR = 1.35 under the log-additive model), and rs2735343 (P = 0.0001, OR = 1.64 for GC)). A significant genotype-dependent variation of lung function parameters was observed for SIRT1 (rs3818292), SIRT3 (rs3782116), PIK3R1 (rs3730089), and MTOR (rs2536). Gene-gene combinations that remained significantly associated with COPD were obtained; the highest risk of COPD was conferred by a combination of G allele of the PIK3R1 (rs831125) gene and GG of SIRT3 (rs536715) (OR = 3.45). The obtained results of polygenic analysis indicate the interaction of genes encoding sirtuins SIRT3, SIRT2, SIRT6 and PI3KR1, PTEN, MTOR and confirm the functional relationship between sirtuins and the PI3K/AKT/mTOR signaling pathway.

Publisher

Institute of Cytology and Genetics, SB RAS

Subject

General Biochemistry, Genetics and Molecular Biology,General Agricultural and Biological Sciences

Reference27 articles.

1. Barnes P.J., Baker J., Donnelly L.E. Cellular senescence as a mechanism and target in chronic lung diseases. Am. J. Respir. Crit. Care Med. 2019;200(5):556-564. DOI: 10.1164/rccm.201810-1975TR.

2. Cai B., Yang L., Do Jung Y., Zhang Y., Liu X., Zhao P., Li J. PTEN: An emerging potential target for therapeutic intervention in respiratory diseases. Oxid. Med. Cell Longev. 2022;2022:4512503. DOI: 10.1155/2022/4512503.

3. Cao L., Liu C., Wang F., Wang H. SIRT1 negatively regulates amyloid-beta-induced inflammation via the NF-κB pathway. Braz. J. Med. Biol. Res. 2013;46(8):659-669. DOI: 10.1590/1414-431X20132903.

4. Chuchalin A.G., Avdeev S.N., Aisanov Z.R., Belevskiy A.S., Leshchenko I.V., Ovcharenko S.I., Shmelev E.I. Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. Pul’monologiya = Pulmonology. 2022;32(3):356-392. DOI: 10.18093/0869-0189-2022-32-3-356-392. (in Russian)

5. Dikalova A.E., Itani H.A., Nazarewicz R.R., McMaster W.G., Flynn C.R., Uzhachenko R., Fessel J.P., Gamboa J.L., Harrison D.G., Dikalov S.I. Sirt3 impairment and SOD2 hyperacetylation in vascular oxidative stress and hypertension. Circ. Res. 2017;121(5):564-574. DOI: 10.1161/CIRCRESAHA.117.310933.